Mark C. Lloyd

4.9k total citations · 1 hit paper
49 papers, 3.5k citations indexed

About

Mark C. Lloyd is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mark C. Lloyd has authored 49 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Mark C. Lloyd's work include Cancer Genomics and Diagnostics (9 papers), Mathematical Biology Tumor Growth (8 papers) and Cancer Cells and Metastasis (7 papers). Mark C. Lloyd is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Mathematical Biology Tumor Growth (8 papers) and Cancer Cells and Metastasis (7 papers). Mark C. Lloyd collaborates with scholars based in United States, United Kingdom and Spain. Mark C. Lloyd's co-authors include Robert J. Gillies, Robert A. Gatenby, Marilyn M. Bui, Jonathan W. Wojtkowiak, Verónica Estrella, Arig Ibrahim‐Hashim, Heather H. Cornnell, Bonnie F. Sloane, Jennifer M. Rothberg and Joseph Johnson and has published in prestigious journals such as Nature Communications, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Mark C. Lloyd

49 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acidity Generated by the Tumor Microenvironment Drives Local Invasion

2013 1.1k citations Verónica Estrella, Tingan Chen et al. Cancer Research profile →

Peers

Countries citing papers authored by Mark C. Lloyd

Since Specialization

Citations

This map shows the geographic impact of Mark C. Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Lloyd more than expected).

Fields of papers citing papers by Mark C. Lloyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Lloyd. The network helps show where Mark C. Lloyd may publish in the future.

Co-authorship network of co-authors of Mark C. Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Lloyd. A scholar is included among the top collaborators of Mark C. Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Lloyd. Mark C. Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamics of Fibril Collagen Remodeling by Tumor Cells: A Model of Tumor-Associated Collagen Signatures 2023 ·Cells ·(unknown), (unknown), Mark C. Lloyd, Mehdi Damaghi, Katarzyna A. Rejniak	10
2	Proton export upregulates aerobic glycolysis 2022 ·BMC Biology ·Shonagh Russell, Liping Xu, Yoonseok Kam, Dominique Abrahams, (unknown), (unknown), Marilyn M. Bui, Joseph Johnson, Tamir Epstein, Epifanio Ruiz, Mark C. Lloyd, Pawel Swietach, Daniel Verduzco, Jonathan W. Wojtkowiak, Robert J. Gillies	13
3	Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution 2017 ·Cancer Research ·Arig Ibrahim‐Hashim, Mark Robertson‐Tessi, Pedro M. Enríquez‐Navas, Mehdi Damaghi, Yoganand Balagurunathan, Jonathan W. Wojtkowiak, Shonagh Russell, Yoonseok Kam, Mark C. Lloyd, Marilyn M. Bui, Joel S. Brown, Alexander R.A. Anderson, Robert J. Gillies, Robert A. Gatenby	89
4	Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins 2017 ·Methods in molecular biology ·Yi Chen, Kate Fisher, Mark C. Lloyd, Elizabeth R. Wood, Domenico Coppola, Erin M. Siegel, David Shibata, Y. Ann Chen, John M. Koomen	5
5	Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia 2015 ·Molecular Imaging and Biology ·Narges K. Tafreshi, Mark C. Lloyd, (unknown), Marilyn M. Bui, Jongphil Kim, Robert J. Gillies, David L. Morse	72
6	Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane 2015 ·Nature Communications ·Mehdi Damaghi, Narges K. Tafreshi, Mark C. Lloyd, Robert W. Sprung, Verónica Estrella, Jonathan W. Wojtkowiak, David L. Morse, John M. Koomen, Marilyn M. Bui, Robert A. Gatenby, Robert J. Gillies	141
7	Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance 2015 ·PLoS ONE ·Daniel Verduzco, Mark C. Lloyd, Liping Xu, Arig Ibrahim‐Hashim, Yoganand Balagurunathan, Robert A. Gatenby, Robert J. Gillies	59
8	An Oct-1-based, feed-forward mechanism of apoptosis inhibited by co-culture with Raji B-cells: Towards a model of the cancer cell/B-cell microenvironment 2014 ·Experimental and Molecular Pathology ·Károly Szekeres, (unknown), (unknown), Mark C. Lloyd, Joseph Johnson, George Blanck	20
9	Acidity Generated by the Tumor Microenvironment Drives Local Invasion breakdown → 2013 ·Cancer Research ·Verónica Estrella, Tingan Chen, Mark C. Lloyd, Jonathan W. Wojtkowiak, Heather H. Cornnell, Arig Ibrahim‐Hashim, Kate Bailey, Yoganand Balagurunathan, Jennifer M. Rothberg, Bonnie F. Sloane, Joseph Johnson, Robert A. Gatenby, Robert J. Gillies	1065
10	Demonstration of a sucrose-derived contrast agent for magnetic resonance imaging of the GI tract 2013 ·Bioorganic & Medicinal Chemistry Letters ·Gary V. Martinez, N. Suryakiran, (unknown), (unknown), Parastou Foroutan, (unknown), (unknown), (unknown), Domenico Coppola, Mark C. Lloyd, Robert J. Gillies, David L. Morse, Eugene A. Mash	3
11	Diagnostic digital cytopathology: Are we ready yet? 2013 ·Journal of Pathology Informatics ·(unknown), Evita Henderson‐Jackson, Joseph Johnson, Mark C. Lloyd, Jasreman Dhillon, Nazeel Ahmad, Ardeshir Hakam, Walid E. Khalbuss, Marino E. Leon, David Chhieng, Xiaohui Zhang, Barbara A. Centeno, Marilyn M. Bui	30
12	Carbonic Anhydrase IX as an Imaging and Therapeutic Target for Tumors and Metastases 2013 ·Sub-cellular biochemistry ·Narges K. Tafreshi, Mark C. Lloyd, Marilyn M. Bui, Robert J. Gillies, David L. Morse	92
13	Chronic Autophagy Is a Cellular Adaptation to Tumor Acidic pH Microenvironments 2012 ·Cancer Research ·Jonathan W. Wojtkowiak, Jennifer M. Rothberg, Virendra Kumar, Karla Schramm, Edward Haller, (unknown), Mark C. Lloyd, Bonnie F. Sloane, Robert J. Gillies	200
14	Autophagy Induced by Conventional Chemotherapy Mediates Tumor Cell Sensitivity to Immunotherapy 2012 ·Cancer Research ·Rupal Ramakrishnan, Chun Huang, Hyun-Il Cho, Mark C. Lloyd, Joseph Johnson, Xiubao Ren, Soner Altiok, Daniel M. Sullivan, Jeffrey S. Weber, Esteban Celis, Dmitry I. Gabrilovich	90
15	Intracellular Electric Field and pH Optimize Protein Localization and Movement 2012 ·PLoS ONE ·Jessica J. Cunningham, Verónica Estrella, Mark C. Lloyd, Robert J. Gillies, B. Roy Frieden, Robert A. Gatenby	20
16	SLC5A8 Nuclear Translocation and Loss of Expression are Associated With Poor Outcome in Pancreatic Ductal Adenocarcinoma 2012 ·Pancreas ·James F. Helm, Domenico Coppola, Vadivel Ganapathy, Mark C. Lloyd, Barbara A. Centeno, Dung‐Tsa Chen, Mokenge P. Malafa, Jong Y. Park	13
17	Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes 2011 ·Clinical Cancer Research ·Narges K. Tafreshi, Marilyn M. Bui, (unknown), Mark C. Lloyd, Steven A. Enkemann, Alexis S. Lopez, Dominique Abrahams, (unknown), Josef Vágner, Stephen R. Grobmyer, Robert J. Gillies, David L. Morse	69
18	A Mammaglobin-A Targeting Agent for Noninvasive Detection of Breast Cancer Metastasis in Lymph Nodes 2010 ·Cancer Research ·Narges K. Tafreshi, Steven A. Enkemann, Marilyn M. Bui, Mark C. Lloyd, Dominique Abrahams, (unknown), Jongphil Kim, Stephen R. Grobmyer, W. Bradford Carter, Josef Vágner, Robert J. Gillies, David L. Morse	45
19	Using image analysis as a tool for assessment of prognostic and predictive biomarkers for breast cancer: How reliable is it? 2010 ·Journal of Pathology Informatics ·Mark C. Lloyd, (unknown), (unknown), Nancy J. Burke, Domenico Coppola, Marilyn M. Bui	72
20	Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray 2010 ·Biochemical Pharmacology ·David L. Morse, (unknown), Galen Hostetter, Maria Trissal, Narges K. Tafreshi, Nancy J. Burke, Mark C. Lloyd, Steven A. Enkemann, Domenico Coppola, Victor J. Hruby, Robert J. Gillies, Haiyong Han	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact